Dr. Doug Lowy | Deputy Director
National Cancer Institute

Douglas Lowy is the Deputy Director of the National Cancer Institute (NCI) part of The National Institutes of Health, and the chief of the Laboratory of Cellular Oncology in the Center for Cancer Research. Dr. Lowy received his medical degree from New York University School of Medicine and trained in internal medicine at Stanford University and dermatology at Yale. Dr. Lowy’s research includes the biology of papillomaviruses and the regulation of normal and neoplastic growth. The papillomavirus research is carried out in close collaboration with John Schiller, with whom he has co-authored more than 100 papers over the past 25 years. Their laboratory was involved in the initial development, characterization, and clinical testing of the preventive virus-like particle-based HPV vaccines that are now used in the two FDA-approved HPV vaccines. Dr. Lowy’s growth regulation research includes prior studies that established the importance of the RAS gene family in cancer and the main mechanisms by which the NF1 tumor suppressor gene regulates normal cell growth. His growth regulation research is now focused primarily on the DLC family of tumor suppressor genes and their mechanism of action. Dr. Lowy is a member of the National Academy of Sciences (NAS), the Institute of Medicine of the NAS, and has received numerous awards for his research.